Coronary Intervention & Surgery

Gregg W. Stone, MD, had the unenviable task of condensing the 255-page agenda for next weekend’s Transcatheter Cardiovascular Therapeutics (TCT) meeting into a handful of highlights during a 12-minute media briefing on Thursday, Sept. 13.

Three decades after the first Transcatheter Cardiovascular Therapeutics conference, TCT.18’s organizers are moving “toward a more practical approach,” says Cardiovascular Research Foundation CEO Juan Granada, MD.

Minimally invasive cardiac surgery without peripheral cannulation is both safe and effective for correcting a wide range of congenital heart defects, including mitral valve repair and pulmonary stenosis, according to research published in Heart, Lung and Circulation this week.

Chronic kidney disease is a marker of adverse outcomes in patients with non-ST-elevation myocardial infarction (non-STEMI), according to a study published this month in the American Journal of Cardiology. And even though percutaneous coronary intervention (PCI) and coronary angiography (CAG) are linked to improved outcomes in those patients, they’re also drastically underutilized in clinical practice.

Joseph D. Babb, MD—who performed the first coronary angioplasty in the state of Connecticut and was a past president of the Society for Cardiovascular Angiography and Interventions (SCAI)—has died, SCAI announced Sept. 6. He was 79.

The family of a Tennessee man who died in 2017, one month after open-heart surgery, is suing TriStar Centennial hospital, alleging the surgeon left a needle inside his body.

Late-breaking results from the VISION study, presented early this week at the European Society of Cardiology (ESC)’s annual symposium, found nearly three-quarters of patient deaths after noncardiac surgery can be attributed to cardiovascular causes.

For patients with acute myocardial infarction (MI) complicated by cardiogenic shock, stenting only the culprit lesion showed a trend toward improved one-year survival when compared to multivessel PCI, according to the latest results of the CULPRIT-SHOCK trial presented at the European Society of Cardiology Congress in Munich.

Intravascular ultrasound may help identify patients who will benefit most from distal protection during percutaneous coronary intervention (PCI), according to a new study published in JACC: Cardiovascular Interventions.

The Avert system successfully reduced contrast media volume but failed to trim the risk of acute kidney injury (AKI) following coronary angiography, according to a trial published in JACC: Cardiovascular Interventions.

The same investigators who ignited debate among interventional cardiologists with the ORBITA trial in November 2017 have now published a small study highlighting the ability of percutaneous coronary intervention (PCI) to immediately reduce ischemia and boost patients’ exercise capacity.

Transcatheter aortic valve replacement (TAVR) has provided relief to thousands of Americans who suffer from leaky heart valves and are too frail to undergo open-heart surgery. But policy and business considerations behind TAVR has large and small hospitals fighting over who will perform the procedures.